BioXcel Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.11 M | $2.98 M | 9.19% | 17.32% |
| OAKTREE CAPITAL MANAGEMENT LP | 08/14/2026 | 1.38 M | $1.95 M | 472.27% | 11.31% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 919.55 K | $1.30 M | 343.50% | 7.53% |
| OAKTREE FUND ADVISORS, LLC | 08/14/2026 | 245.59 K | $346.27 K | 472.29% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 242.25 K | $341.91 K | 5.25% | 1.98% |
| BLACKROCK, INC. | 08/07/2026 | 179.43 K | $253.00 K | 112.90% | 1.47% |
| UBS GROUP AG | 08/13/2026 | 158.07 K | $222.87 K | 199.43% | 1.29% |
| CITADEL ADVISORS LLC | 09/02/2026 | 149.22 K | $210.40 K | 100.00% | 1.22% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 136.94 K | $193.08 K | 61.25% | 1.12% |
| STATE STREET CORP | 09/22/2026 | 92.12 K | $129.89 K | 0.00% | 0.75% |
| FMR LLC | 08/13/2026 | 90.30 K | $127.32 K | 0.00% | 0.74% |
| WILEY BROS.-AINTREE CAPITAL, LLC | 08/14/2026 | 83.59 K | $117.86 K | 3.37% | 0.68% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 63.14 K | $82.71 K | -52.09% | 0.52% |
| NORTHERN TRUST CORP | 08/13/2026 | 56.32 K | $79.41 K | 55.09% | 0.46% |
| HIGHTOWER ADVISORS, LLC | 08/05/2026 | 41.00 K | $57.81 K | 0.00% | 0.34% |
| QUADRATURE CAPITAL LTD | 08/07/2026 | 38.04 K | $53.63 K | 100.00% | 0.31% |
| HEADLANDS TECHNOLOGIES LLC | 08/13/2026 | 25.56 K | $36.03 K | 100.00% | 0.21% |
| STONEX GROUP INC. | 08/12/2026 | 20.68 K | $29.16 K | 100.00% | 0.17% |
| BEACON POINTE ADVISORS, LLC | 08/18/2026 | 18.84 K | $26.56 K | -0.21% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 17.20 K | $24.25 K | 100.00% | 0.14% |
| PORTFOLIO STRATEGIES, INC. | 08/10/2026 | 16.83 K | $23.73 K | 38.21% | 0.14% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 16.21 K | $22.86 K | 0.00% | 0.13% |
| VIRTU FINANCIAL LLC | 08/13/2026 | 15.97 K | $23.00 K | 100.00% | 0.13% |
| DIVERSIFY ADVISORY SERVICES, LLC | 08/10/2026 | 15.00 K | $13.01 K | 100.00% | 0.12% |
| DIVERSIFY WEALTH MANAGEMENT, LLC | 07/30/2026 | 15.00 K | $13.01 K | 0.00% | 0.12% |
| TWO SIGMA SECURITIES, LLC | 08/14/2026 | 10.80 K | $15.22 K | 100.00% | 0.09% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 4.34 K | $6.12 K | 0.42% | 0.04% |
| CITIGROUP INC | 08/03/2026 | 3.00 K | $4.23 K | 100.00% | 0.02% |
| MORGAN STANLEY | 08/13/2026 | 1.67 K | $2.36 K | -84.22% | 0.01% |
| BARCLAYS PLC | 08/14/2026 | 1.43 K | $2.01 K | 100.00% | 0.01% |
| NEWEDGE ADVISORS, LLC | 08/12/2026 | 1.33 K | $1.88 K | 0.00% | 0.01% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 493 | $695 | 0.00% | 0.00% |
| SILVER GROVE FINANCIAL GROUP, INC. | 08/13/2026 | 331 | $468 | -0.90% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 227 | $320 | -86.79% | 0.00% |
| PARKSIDE FINANCIAL BANK & TRUST | 09/04/2026 | 112 | $158 | 0.00% | 0.00% |
| WASHINGTON TRUST ADVISORS, INC. | 07/29/2026 | 82 | $116 | -48.75% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 07/24/2026 | 60 | $85 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 45 | $63 | 0.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 32 | $45 | 100.00% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 07/17/2026 | 25 | $35 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 21 | $30 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 07/20/2026 | 13 | $18 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 13 | $18 | -7.14% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 12 | $17 | -79.66% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 08/12/2026 | 2 | $3 | 0.00% | 0.00% |
| US BANCORP \DE\ | 08/12/2026 | 1 | $1 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 1 | $1 | 0.00% | 0.00% |
| TRIUMPH CAPITAL MANAGEMENT | 07/21/2026 | 1 | $1 | 0.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MAN GROUP PLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
BioXcel Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 62 institutional investors and hedge funds held shares of BioXcel Therapeutics Inc. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 2.11 M
OAKTREE CAPITAL MANAGEMENT LP: 1.38 M
VANGUARD CAPITAL MANAGEMENT LLC: 919,545
Oaktree Fund Advisors, LLC: 245,585
GEODE CAPITAL MANAGEMENT, LLC: 242,251
BlackRock, Inc.: 179,433
50.59% of BioXcel Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.92 M shares in the last 24 months. This purchase volume represents approximately $11.97 M in transactions.